Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0000950170-25-055856
Filing Date
2025-04-18
Accepted
2025-04-18 16:05:04
Documents
6
Period of Report
2025-06-09

Document Format Files

Seq Description Document Type Size
1 PRE 14A sprb-predef14a-2025.htm PRE 14A 770504
2 GRAPHIC img191538130_0.jpg GRAPHIC 2036
3 GRAPHIC img191538130_1.jpg GRAPHIC 3052
4 GRAPHIC img191538130_2.jpg GRAPHIC 3052
5 GRAPHIC img191538130_3.jpg GRAPHIC 148765
6 GRAPHIC img191538130_4.jpg GRAPHIC 124872
  Complete submission text file 0000950170-25-055856.txt   1160304
Mailing Address 611 GATEWAY BOULEVARD, SUITE 740 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BOULEVARD, SUITE 740 SOUTH SAN FRANCISCO CA 94080 (415) 655-4168
SPRUCE BIOSCIENCES, INC. (Filer) CIK: 0001683553 (see all company filings)

EIN.: 812154263 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-39594 | Film No.: 25850471
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)